Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

New exchange: Nasdaq First North

FluoGuide A/S – Flagging message

Press release


May 17, 2020

FluoGuide A/S (“FluoGuide” or “the Company”) hereby announce that due to dilution in connection to the warrant exercise for warrants of series TO 1, that was fully exercised, Wexotec ApS, which is CEO Morten Albrechtsen’s fully owned company that owns 1,487,394 shares in FluoGuide, passes the 15 percent limit. Wecotec ApS shareholdings goes from approx. 15.7 percent of the shares in the Company to owning approx. 14.1 percent.